Taxotere Survey

The popular chemotherapy medication Taxotere may be linked to an increased risk of permanent hair loss (alopecia). Those affected may be entitled to compensation and are encouraged to complete this short survey.

Please note: completion of this evaluation does not guarantee compensation. Each project has specific qualifying criteria and the criteria may change from time-to-time. In some instances, users who are not immediately contacted may be contacted at a later date.

Progress

0%
100%